Cetera Investment Advisers
GTBP icon

Cetera Investment Advisers’s GT Biopharma GTBP Stock Holding History

Cetera Investment Advisers’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Buy
+55,936
New +$22.7K ﹤0.01% 4826

Other funds holding GTBP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
KP
Kitching Partners Conshohocken, Pennsylvania $116M AUM 16.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cetera Investment Advisers's GTBP Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in GT Biopharma (GTBP) in Q2 2026: 55,936 shares worth $27.4K. The stake represents ﹤0.01% of the portfolio and ranks #4826 among its holdings.

43 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Cetera Investment Advisers held 55,936 shares of GT Biopharma worth $27.4K as of Q2 2026.
  • GT Biopharma was a new Cetera Investment Advisers position in Q2 2026.
  • GT Biopharma made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4826 holding.
  • 43 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.